Stratec Posts Impressive Q2 Recovery, Faces Challenging Q3 Growth

Stratec SE reported a Q2 recovery in its latest financials. The company's adjusted EBIT margin rose to 11.9 percent, up from 2.2 million euros in Q2 2025 to 5.6 million euros this year.

The revenue for Q2 2026 was 59.1 million euros, a 2.4 percent increase year-over-year at constant currency. This growth was led by the Analyzer Systems segment, which improved significantly.

However, the Service Parts and Consumables segment remained weaker compared to last year's numbers. The company's Q3 will be crucial in meeting its revenue targets for 2026, requiring growth of 12-22 percent over the second half of 2025.

The analyst consensus remains Overweight, with an average price target of 27.17 euros per share. However, mwb research downgraded their rating from Hold to Sell due to concerns about customer demand and volatility in Q3.